Cite
MLA Citation
L Peyrin-Biroulet et al.. “DOP73 A comparative efficacy and safety analysis of subcutaneous infliximab and vedolizumab in patients with Crohn's Disease and Ulcerative Colitis.” Journal of Crohn's and colitis, vol. 16, n.d., pp. i116–i117. http://access.bl.uk/ark:/81055/vdc_100150515225.0x00002f